371 related articles for article (PubMed ID: 36831318)
1. Role of Deubiquitinases in Parkinson's Disease-Therapeutic Perspectives.
Nielsen PYØ; Okarmus J; Meyer M
Cells; 2023 Feb; 12(4):. PubMed ID: 36831318
[TBL] [Abstract][Full Text] [Related]
2. Precise control of mitophagy through ubiquitin proteasome system and deubiquitin proteases and their dysfunction in Parkinson's disease.
Park GH; Park JH; Chung KC
BMB Rep; 2021 Dec; 54(12):592-600. PubMed ID: 34674795
[TBL] [Abstract][Full Text] [Related]
3. Interaction between Parkin and
Madsen DA; Schmidt SI; Blaabjerg M; Meyer M
Cells; 2021 Jan; 10(2):. PubMed ID: 33572534
[TBL] [Abstract][Full Text] [Related]
4. SIAH proteins regulate the degradation and intra-mitochondrial aggregation of PINK1: Implications for mitochondrial pathology in Parkinson's disease.
Abd Elghani F; Safory H; Hamza H; Savyon M; Farhoud M; Toren-Hershoviz M; Vitic Z; Ebanks K; Shani V; Bisharat S; Shaulov L; Brodski C; Song Z; Bandopadhyay R; Engelender S
Aging Cell; 2022 Dec; 21(12):e13731. PubMed ID: 36307912
[TBL] [Abstract][Full Text] [Related]
5. The Ubiquitin Proteasome System as a Therapeutic Area in Parkinson's Disease.
Suresh K; Mattern M; Goldberg MS; Butt TR
Neuromolecular Med; 2023 Sep; 25(3):313-329. PubMed ID: 36739586
[TBL] [Abstract][Full Text] [Related]
6. Parkin and defective ubiquitination in Parkinson's disease.
Dawson TM
J Neural Transm Suppl; 2006; (70):209-13. PubMed ID: 17017531
[TBL] [Abstract][Full Text] [Related]
7. Molecular chaperones and Parkinson's disease.
Hu S; Tan J; Qin L; Lv L; Yan W; Zhang H; Tang B; Wang C
Neurobiol Dis; 2021 Dec; 160():105527. PubMed ID: 34626793
[TBL] [Abstract][Full Text] [Related]
8. The Role of Ubiquitin-Proteasome System and Mitophagy in the Pathogenesis of Parkinson's Disease.
Liang Y; Zhong G; Ren M; Sun T; Li Y; Ye M; Ma C; Guo Y; Liu C
Neuromolecular Med; 2023 Dec; 25(4):471-488. PubMed ID: 37698835
[TBL] [Abstract][Full Text] [Related]
9. The three 'P's of mitophagy: PARKIN, PINK1, and post-translational modifications.
Durcan TM; Fon EA
Genes Dev; 2015 May; 29(10):989-99. PubMed ID: 25995186
[TBL] [Abstract][Full Text] [Related]
10. Age- and disease-dependent increase of the mitophagy marker phospho-ubiquitin in normal aging and Lewy body disease.
Hou X; Fiesel FC; Truban D; Castanedes Casey M; Lin WL; Soto AI; Tacik P; Rousseau LG; Diehl NN; Heckman MG; Lorenzo-Betancor O; Ferrer I; Arbelo JM; Steele JC; Farrer MJ; Cornejo-Olivas M; Torres L; Mata IF; Graff-Radford NR; Wszolek ZK; Ross OA; Murray ME; Dickson DW; Springer W
Autophagy; 2018; 14(8):1404-1418. PubMed ID: 29947276
[TBL] [Abstract][Full Text] [Related]
11. Ubiquitination of a new form of alpha-synuclein by parkin from human brain: implications for Parkinson's disease.
Shimura H; Schlossmacher MG; Hattori N; Frosch MP; Trockenbacher A; Schneider R; Mizuno Y; Kosik KS; Selkoe DJ
Science; 2001 Jul; 293(5528):263-9. PubMed ID: 11431533
[TBL] [Abstract][Full Text] [Related]
12. Ubiquitination of alpha-synuclein by Siah-1 promotes alpha-synuclein aggregation and apoptotic cell death.
Lee JT; Wheeler TC; Li L; Chin LS
Hum Mol Genet; 2008 Mar; 17(6):906-17. PubMed ID: 18065497
[TBL] [Abstract][Full Text] [Related]
13. The regulatory role of α-synuclein and parkin in neuronal cell apoptosis; possible implications for the pathogenesis of Parkinson's disease.
Yasuda T; Mochizuki H
Apoptosis; 2010 Nov; 15(11):1312-21. PubMed ID: 20221696
[TBL] [Abstract][Full Text] [Related]
14. Ubiquitination of alpha-synuclein and autophagy in Parkinson's disease.
Engelender S
Autophagy; 2008 Apr; 4(3):372-4. PubMed ID: 18216494
[TBL] [Abstract][Full Text] [Related]
15. Counteracting PINK/Parkin Deficiency in the Activation of Mitophagy: A Potential Therapeutic Intervention for Parkinson's Disease.
Nardin A; Schrepfer E; Ziviani E
Curr Neuropharmacol; 2016; 14(3):250-9. PubMed ID: 26517048
[TBL] [Abstract][Full Text] [Related]
16. Deubiquitinating enzyme YOD1 deubiquitinates and destabilizes α-synuclein.
Park SS; Do HA; Park HB; Choi HS; Baek KH
Biochem Biophys Res Commun; 2023 Feb; 645():124-131. PubMed ID: 36682332
[TBL] [Abstract][Full Text] [Related]
17. [Pathogenesis of Parkinson's disease: a common pathway between alpha-synuclein and parkin and the mechanism of Lewy bodies formation].
Hattori N; Machida Y; Noda K
Rinsho Shinkeigaku; 2005 Nov; 45(11):905-7. PubMed ID: 16447759
[TBL] [Abstract][Full Text] [Related]
18. Inclusion body formation and neurodegeneration are parkin independent in a mouse model of alpha-synucleinopathy.
von Coelln R; Thomas B; Andrabi SA; Lim KL; Savitt JM; Saffary R; Stirling W; Bruno K; Hess EJ; Lee MK; Dawson VL; Dawson TM
J Neurosci; 2006 Apr; 26(14):3685-96. PubMed ID: 16597723
[TBL] [Abstract][Full Text] [Related]
19. Identification of a highly neurotoxic α-synuclein species inducing mitochondrial damage and mitophagy in Parkinson's disease.
Grassi D; Howard S; Zhou M; Diaz-Perez N; Urban NT; Guerrero-Given D; Kamasawa N; Volpicelli-Daley LA; LoGrasso P; Lasmézas CI
Proc Natl Acad Sci U S A; 2018 Mar; 115(11):E2634-E2643. PubMed ID: 29487216
[TBL] [Abstract][Full Text] [Related]
20. Ubiquitin-proteasome system and Parkinson's diseases.
Betarbet R; Sherer TB; Greenamyre JT
Exp Neurol; 2005 Feb; 191 Suppl 1():S17-27. PubMed ID: 15629758
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
